Operator
Good day, and thank you for standing by. Welcome to the Mettler-Toledo Quarterly Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Ms. Mary Finnegan. Please go ahead.
Mary T. Finnegan
Head of Internal Relations and Treasurer
Thank you, and good evening, everyone. I m Mary Finnegan. I m responsible for Investor Relations at Mettler-Toledo and happy to welcome you to the call. I m joined on the call today with Patrick Kaltenbach, our CEO; and Shawn Vadala, our Chief Financial Officer. Let me cover just a couple of administrative matters. This call is being webcast and is available for replay on our website. A copy of the press release and the presentation that we will refer to on today s call is also available on the website.
Operator
Good afternoon, ladies and gentlemen, and welcome to the Q2 2021 Bio-Rad Laboratories, Inc. Financial Results Conference Call. [Operator Instructions]
I would now like to turn the conference over to your host, Mr. Edward Chung, Head of Investor Relations. Sir, please go ahead.
Edward Chung
Vice President of Investor Relations
Thank you, Joanna. Good afternoon. Thank you all for joining us. Today, we will review the second quarter 2021 financial results and provide an update on key business trends for Bio-Rad. With me on the phone today are Norman Schwartz, our Chief Executive Officer; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Annette Tumolo, President of the Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group. Before we begin our review, I d like to caution everyone that we will be making forward-looking statements about management s goals, plans, ex